NCT06417684View on ClinicalTrials.gov

Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 19, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Vestibular Migraine

Interventions

DRUG

Amitriptyline

25 mg prescribed to be taken once daily for 90 days each evening.

BEHAVIORAL

Lifestyle Modification

Written and video instructions to instruct the participant to improve restful sleep, exercise, avoidance of dietary triggers, and mealtime regularity.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors

lead

Vanderbilt University Medical Center

OTHER